Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

    Limited submission

    NIH's limited competition funds eligible institutions to establish hubs offering proof-of-concept funding, commercialization resources, and mentorship to turn biomedical discoveries into products.

    Browse similar grants
    Limited Submission Grant Opportunities
    OverviewSimilar Grants
    OverviewSimilar Grants

    Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

    This grant will fund partnerships to expand the use and integration of BRAIN Initiative neurotechnologies at institutions with limited NIH research funding, supporting two-way knowledge transfer and training.

    HHS-NIH11Forecasted Jun 17, 2027Forecasted

    Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

    The NIH will soon offer grants to support early-career scientists at US small businesses, funding both research and entrepreneurial training, with required mentoring for first-time principal investigators.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

    This upcoming NIH and CDC grant supports early-career scientists at US small businesses with funding, entrepreneurial training, and mentoring to help them transition into entrepreneurship.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)

    NIH's limited competition supports expansion and sustainability of biomedical research centers at eligible institutions in states with historically low NIH funding; clinical trials are not allowed.

    HHS-NIH11Due Jan 25, 2027$7,500,000

    NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

    NIH supports development of next-generation diagnostic and therapeutic devices aligned with its brain research and addiction initiatives, preparing them for first-in-human trials; clinical trials are not allowed.

    HHS-NIH11Due Feb 1, 2027$2,250,000